USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: ORGAN RECOVERY SYSTEMS, INC.
City: CHARLESTON
State: SC
Zip+4: 29403-0500
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (843) 514-6164

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,623,270.00 16
SBIR Phase II $3,037,849.00 4
STTR Phase I $115,772.00 1

Award List:

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael J. Taylor
Award Amount: $100,000.00
Abstract:
Not Available One of the many advantages of diffractive optics over traditional refractive optics is the vastly larger degrees of freedom available in the design and application of optical elements. Advances in manufacturing technology now make it possible to physicall

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kelvin G. Brockbank
Award Amount: $100,000.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lia H. Campbell
Award Amount: $100,270.00

VITRIFICATION OF GENETICALLY-ENGINEERED ISLETS

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael J. Taylor
Award Amount: $111,280.00
Abstract:
Transplantation of pancreatic islets for the treatment of diabetes mellitus is widely anticipated to eventually provide a cure once a means for preventing rejection is found without reliance upon global immunosuppression. Long-term storage of islets is crucial for the organization of… More

VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ying C. Song
Award Amount: $100,000.00
Abstract:
DESCRIPTION (Verbatim From Applicant's Abstract): Effective methods of preservation are irnportant for the remerging technology of tissue engineering. We recently demonstrated, for the first time, that vitrification can have a salutary effect on the cryopreservation of a… More

IMPROVED ALLOGRAFT HEART VALVE PRESERVATION

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kelvin G. Brockbank
Award Amount: $0.00
Abstract:
Cryopreserved allogeneic human heart valves are presently the preferred aortic and pulmonary heart valve prostheses for pediatric patients, women of child-bearing age and non-drug compliant patients. Unfortunately, these valves often deteriorate in younger pediatric patients.… More

IMPROVED ALLOGRAFT HEART VALVE PRESERVATION

Award Year / Program / Phase: 2002 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kelvin G. Brockbank
Award Amount: $804,937.00
Abstract:
Cryopreserved allogeneic human heart valves are presently the preferred aortic and pulmonary heart valve prostheses for pediatric patients, women of child-bearing age and non-drug compliant patients. Unfortunately, these valves often deteriorate in younger pediatric patients.… More

VITRIFICATION FOR TISSUE ENGINEERED PANCREAS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ying C. Song
Award Amount: $105,373.00
Abstract:
DESCRIPTION (provided by applicant): According to current estimates from the American Diabetes Association, there are approximately 16 million diabetics in the U.S. in 2000, with 600,000 to 800,000 afflicted with Type I insulin-dependent diabetes (IDD). Tissue engineered pancreatic substitutes have… More

CRYOPRESERVATION OF ARTICULAR CARTILAGE BY VITRIFICATION

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kelvin G. Brockbank
Award Amount: $0.00
Abstract:
Fresh osteochondral allografts have been proven clinically effective. However, the logistics of getting fresh, viable cartilage from donor to recipient requires the development of tissue banking methods. Conventional cryopreserved osteochondral grafts perform poorly in vivo and it is well… More

CRYOPRESERVATION OF ARTICULAR CARTILAGE BY VITRIFICATION

Award Year / Program / Phase: 2002 / SBIR / Phase II
Agency: HHS
Principal Investigator: Kelvin G. Brockbank
Award Amount: $883,081.00
Abstract:
Fresh osteochondral allografts have been proven clinically effective. However, the logistics of getting fresh, viable cartilage from donor to recipient requires the development of tissue banking methods. Conventional cryopreserved osteochondral grafts perform poorly in vivo and it is well… More

STEM CELL PRESERVATION WITH NONTOXIC SUGARS

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: John R. Walsh
Award Amount: $100,920.00
Abstract:
DESCRIPTION (provided by applicant): Diseases of the bone marrow that may be treated with cryopreserved hemopoletic stem cell transplantation indude the leukemias, lymphomas and aplastic anemia. In the field of cryopreservation, current opinion is that cryoprotective agents should be removed prior… More

MOLECULAR ICE CONTROL FOR ENGINEERED TISSUES

Award Year / Program / Phase: 2002 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael J. Taylor
Award Amount: $213,999.00
Abstract:
DESCRIPTION (provided by applicant): Long term preservation is crucial as an enabling technology for tissue engineering. Cryopreservation would provide an ideal solution to this need except that ice crystallization in complex multicomponent tissues causes injury to the cells and the extracellular… More

PRESERVATION OF MYOCARDIAL TISSUE-ENGINEERED CONSTRUCTS

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: John R. Walsh
Award Amount: $122,006.00
Abstract:
DESCRIPTION (provided by applicant): Cell-based tissue engineering approaches to myocardial repair are 21st century solutions to an intractable problem. Because the adult heart lacks a pool of cells to effect repairs, it is incapable of effective cardiomyocyte regeneration after injury or… More

PANCREAS TRANSPORTER DEVELOPMENT AND FEASIBILITY TESTING

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: John Brassil
Award Amount: $162,076.00
Abstract:
DESCRIPTION (provided by applicant): Diabetes mellitus is the fourth leading cause of death by disease in the U.S. Recent studies presented by the Edmonton Group have resulted in a widespread belief that implantation of allogeneic, glucose-responsive, insulin-secreting Islets of Langerhans for the… More

ORGAN CROPRESERVATION USING MOLECULAR ICE CONTROL

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: John R. Walsh
Award Amount: $130,342.00
Abstract:
DESCRIPTION (provided by applicant): Donated organs are used to extend life for thousands of people each year. Unfortunately, the availability of donor organs is greatly outweighed by current demand causing enormous shortages. The problem is compounded by the time critical nature of… More

Development of Cryoplates for Cytotoxicity Testing

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Lia H. Campbell
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): Advancements in high throughput screening, and mandates all over the world to reduce animal testing, have driven the development of a variety of assays to evaluate potentially new drugs and their side effects. Environmental monitoring of potentially harmful… More

Development of Cryoplates for Cytotoxicity Testing

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency: HHS
Principal Investigator: Lia H. Campbell
Award Amount: $552,032.00
Abstract:
DESCRIPTION (provided by applicant): Advancements in high throughput screening, and mandates all over the world to reduce animal testing, have driven the development of a variety of assays to evaluate potentially new drugs and their side effects. Environmental monitoring of potentially harmful… More

VITRIFICATION FOR TISSUE ENGINEERED BLOOD VESSELS

Award Year / Program / Phase: 2004 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ying C. Song
Award Amount: $797,799.00
Abstract:
DESCRIPTION (provided by applicant): Although significant advances have been made in the field, the critical issues of mechanical strength and long-term storage methods limit progress in engineered vessels. It is well established that traditional cryopreservation results in damaging ice… More

pH MANAGEMENT IN HYPOTHERMICALLY STORED CARDIOMYOCYTES

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Simona C. Baicu
Award Amount: $157,928.00
Abstract:
DESCRIPTION (provided by applicant): Organ transplantation remains the only available therapy for end-stage disease, thus a large donor pool is deemed essential to satisfy the current clinical organ demand. The use of hypothermia for isolated organ preservation has been proven an effective… More

ICE-FREE PRESERVATION OF OVARIES FOR LONG-TERM FECUNDITY

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ying C. Song
Award Amount: $119,076.00
Abstract:
DESCRIPTION (provided by applicant): There are more than 50,000 reproductive age women who are exposed to sterilizing chemotherapy and radiotherapy annually in the U.S. alone and thousands lose their ovarian function due to gynecologic surgery. Cryopreservation of ovarian tissue prior to initiation… More